• Login
    • Join
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Formulary
    • Exclusives
    • Top Companies
    • Raw Materials
    • End-User
    • Packaging
    • Directories
    • Events
    • Jobs
    • More
  • Magazine
  • News
  • Formulary
  • Exclusives
  • Top Companies
  • Raw Materials
  • End-User
  • Packaging
  • Directories
  • Events
  • Jobs
  • Current / Back Issues
    Features
    Columns
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    In Sickness & in Health

    In Action

    Tress Test

    From Hollywood to Hair Color

    Virtual Reality for Makeup Is Not Make Believe
    Online Exclusives
    Association News
    Breaking News
    Financial News
    Industry News
    International
    Marketing News
    New Products
    News Front
    Packaging News
    Patents
    Personnel
    Regulations
    Snapshots
    Top News
    Live From Shows
    Top News
    Jennifer Garner Joins Virtue Labs

    Perfect Corp. Partners with Sally Beauty

    Dollar General To Sell CBD Beauty

    Nouryon Introduces Natural Starch for Personal Care

    Caribbean Natural Taps New Sales Rep
    Blog
    Online Exclusives
    Infographics
    Podcasts
    Whitepapers
    Videos
    Expert's Opinion
    eBook
    Surveys
    International Top 30 Report
    Top 50 Report
    Top Companies
    3. Colgate-Palmolive

    35. Energizer

    24. Inter Parfums

    11. Yves Rocher

    14. LG Household Healthcare
    Actives
    Functional Ingredients
    Pigments
    Polymers
    Preservatives
    Surfactants

    Givaudan Unveils RitualEssenz Brazil

    Where Angels Soar

    Croda Awarded for Reputation

    DSM and Metex Nøøvista Collaborate

    FDA May Change Manufacturing Survey
    Air Care/Environmental Fragrance
    AP/Deo
    Color Cosmetics
    Disinfectants
    Fine Fragrance
    Hair Care
    Household Cleaning
    I&I Marketplace
    Laundry Care
    Oral Care
    OTC/Medicated
    Packaging
    Personal Cleansers
    Skin Care
    Sun Care
    Testing

    Jennifer Garner Joins Virtue Labs

    Perfect Corp. Partners with Sally Beauty

    Dollar General To Sell CBD Beauty

    Caribbean Natural Taps New Sales Rep

    HCPA and ACI React to 1,4-Dioxane Bill
    Lab Equipment
    Mixing
    Packaging
    Testing

    Seven of the Best Ideas in Beauty Sustainability

    Love Beauty and Planet Addresses Waste

    A New Era in Efficacy Testing

    Circular Models for Consumer Staples

    CPI Works to Reduce Formulation Risks
    Contract Manufacturing / Private Label Directory
    Buyer's Guide
    Add New Company
    Corporate Profiles
    International Buyers Guide Companies
    Tokiwa Cosmetics America, LLC

    Accupac

    Sabinsa Cosmetics, a division of Sabinsa Corporation

    Siltech Corporation

    Croda
    Live From Shows
    Meetings
    Webinars
    Snapshots
    • Magazine
      • Current / Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Formulary
    • Directories
      • Buyer's Guide
      • Contract Manufacturing / Private Label Directory
      • Corporate Profiles
      • Add Your Company
    • Raw Materials
      • Actives
      • Functional Ingredients
      • Pigments
      • Polymers
      • Preservatives
      • Surfactants
    • End-User
      • Air Care/Environmental Fragrance
      • AP/Deo
      • Color Cosmetics
      • Disinfectants
      • Fine Fragrance
      • Hair Care
      • Household Cleaning
      • I&I Marketplace
      • Laundry Care
      • Oral Care
      • OTC/Medicated
      • Packaging
      • Personal Cleansers
      • Skin Care
      • Sun Care
      • Testing
    • Packaging
      • Lab Equipment
      • Mixing
      • Packaging
      • Testing
    • Top Companies
      • International Top 30 Report
      • Top 50 Report
    • Online Exclusives
    • Experts Opinion
    • Slideshows
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Blog
    • Whitepapers
    • Surveys
      • R & D Salary Survey
      • Sales & Marketing Salary Survey
    • Job Banks
    • Events
      • Industry Events
      • Live from show Events
      • Webinars
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Sunscreen Filter

    FDA Proposal: Part I Is the Wait Finally Over?

    Related CONTENT
    • Me, Myself and I
    • Testing, Testing
    • Exsymol Helps Brands Formulate Custom Products
    • LipoTrue Awarded Certification
    • FDA Seeks Comments on Proposed Consumer Survey about Allergens in Cosmetics
    Nadim Shaath, Alpha Research & Development Ltd04.01.19
    On Feb. 26, 2019, the US FDA published a “proposed” rule that would put into effect a final monograph for non-prescription OTC sunscreen drug products.1 It is being published to comply with the Federal Food, Drug and Cosmetic Act (FD&C Act) as amended by the Sunscreen Innovation Act (SIA) that we at the PASS (Public Access to SunScreen) Coalition lobbied for successfully in 2014. Written or electronic comments will be accepted by the FDA 90 days after the publication date, or by May 26, 2019.


    Due to the importance of this document, I will devote two columns on the subject. Here, I will outline what the FDA is proposing. Next month, I will offer my comments and critique of the FDA’s Proposed Rule. The “Final Monograph” for non-prescription, OTC sunscreen drug products establishes conditions under which certain OTC drugs may be marketed without approved new drug applications because they are GRASE (Generally Recognized as Safe and Effective) and are not misbranded. The proposed rule classifies active ingredients as Category I (GRASE and not misbranded), Category II (not GRASE or misbranded) and Category III (additional data needed). Twenty years ago, on May 21, 1999, the FDA published the “Final Rule” and then on June 17, 2011, “stayed,” i.e., invalidated the earlier issued 1999 ruling, and then required additional data regarding the safety of the individual sunscreen active ingredients. Shortly thereafter, a group of sunscreen and UV filter suppliers collaborated with some health advocates and sunscreen experts to form the PASS Coalition as a lobbying group in Washington, DC.


    Our efforts in Congress to demonstrate the need for more effective ultraviolet filters (the pending TEA ingredients and others) culminated in the passing of the SIA bill and the signing into law by President Barack Obama on November 26, 2014. The SIA calls for the FDA to issue a final OTC sunscreen monograph to be effective within five years of enactment (Section 586 E(a) of the FD&C Act). So, the time line for enacting a final rule is November 25, 2019, a mere seven months from now!


    In Summary…
    Here is a summary of the major provisions of the Proposed Rule:

    1. Proposed GRASE Status of Active Ingredients listed in the stayed 1999 Final Monograph. According to the FDA only zinc oxide and titanium dioxide (at concentrations of up to 25%) would be GRASE and are Category I ingredients. Two other ingredients, namely PABA and trolamine salicylate, were classified as Category II; i.e., cannot be used anymore in sunscreen products. The FDA proposed that the remaining 12 ingredients be classified as Category III; i.e., require further testing. The FDA acknowledges that all 12 of these UV filters have limited data—or no data—characterizing their absorption. It specifically singled out oxybenzone being absorbed through the skin to a greater extent than previously understood.

    2. Proposed Requirements Related to Dosage Forms. In 2011, the FDA published an ANPR (Advanced Notice of Proposed Rule Making) identifying sunscreen dosage forms. This new proposal identifies the following dosage forms as Category I: oils, lotions, creams, gels, butters, pastes, ointments and sticks. As for “sprays” they would be considered Category I subject to further testing necessary to minimize potential risks from unintended inhalation (particle size restrictions), flammability, drying time testing and related labeling requirements. The FDA proposes to classify “powders” as Category III and that sunscreens in all other dosage forms, including “wipes, towelettes, body wash and shampoos,” are new drugs because the FDA did not receive data showing that they were marketed prior to 1972, as required for inclusion in the monograph.

    3. Proposed Maximum SPF and Broad Spectrum Requirements. The 1978 ANPR set SPF 15 as the maximum labeled SPF value, the 1999 Final Monograph (now stayed) established SPF 30+ as the maximum labeled SPF value and subsequently in 2011 raised the value to 50+. In this Proposed Rule (2019) the maximum allowed will be an SPF of 60+. The proposal permits the marketing of SPF values up to 80 and would allow sunscreen products with SPF values above 80 with an approved NDA. The FDA has raised concerns about the potential for inadequate UVA protection—particularly in high SPF sunscreen products. To address these concerns, FDA proposes that all sunscreen products with SPF values of 15 and above satisfy broad spectrum requirements and meet UVAI/UV ratio of 0.7 or higher. Finally, the proposal calls for testing at SPF 30 or more be labeled in increments of 10 (e.g., SPF 30, 40, 50, 60+) and sunscreen testing at SPF 15 to 29 be labeled in increments of 5 (e.g., SPF 15, 20, 25) and no ranges are required for SPFs below 15.

    4. Proposed PDP Labeling Re-quirements. A major feature of the Principal Display Panel is the Statement of Identity (SOI). The FDA proposes that the SOI consist of alphabetical listing of the sunscreen active ingredients in the product, followed by “sunscreen” and the product’s dosage form (such as lotion or spray). Other changes to the format of the PDP are also proposed.

    5. Proposed Requirements Related to Final Formulation Testing Process and Record Keeping. The FDA is proposing to require records of the testing of sunscreen products to be maintained for one year after three years from the distribution of the last lot of the product.  Other revisions will also be required.

    6. Proposed Status of Sunscreen – Insect Repellent Combination Products. The FDA proposes to classify these products as Category II because of incompatibilities between FDA and EPA labeling requirements.

    7. Proposed Actions to Effectuate Lifting of Stay and Harmonize Impacted Regulations. The FDA proposes to lift the stay on the 1999 Final Monograph subject to the revision of this proposed Final Rule.


    On Feb. 27, FDA commissioner Dr. Scott Gottlieb testified before the House Agriculture-Rural Development Appropriations Subcommittee to answer questions regarding FDA’s ongoing activities related to congressional funding. During the hearing, Rep. John Moolenaar (R-MI) asked the Commissioner about the proposed Sunscreen Rule issued a day earlier. 


    Specifically, he asked about the 90-day data submission timeline for the existing 12 ingredients to conform with the rule. Gottlieb replied that the ingredients would not be banned or come off the market and that the manufacturers of those 12 ingredients for which the FDA is requesting additional data to make a GRASE determination, can request a deferral to gain more time to collect and submit data while the proposed rule is finalized. During this data submission period, the ingredients would remain on the market during the review process. He also predicted that the agency is expecting six to eight of those 12 ingredients to receive deferrals. (Last month, Gottlieb resigned as FDA Commissioner. At press time, President Donald J. Trump had not announced a nominee to replace him.)


    I will comment and critique the specific proposals next month’s The Sunscreen Filter column. Stay tuned! 

    References:
    1. www.fda.gov/Drugs/DevelopmentApprovalProcess/


    Nadim Shaath
    Alpha Research & Development Ltd
    Email: alpharnd@aol.com

    Dr. Nadim Shaath is the president of Alpha Research & Development, Ltd. in White Plains, NY. He has over 30 years of experience as chairman of the chemistry department at SUNY-Purchase and the CEO of Kato Worldwide. Recently he published his new book entitled “Healing Civilizations: The Search for Therapeutic Essential Oils and Nutrients” Cameron Books, Petaluma, CA. 
    Related Searches
    • uv
    • us fda
    • epa
    • body wash
    Related Knowledge Center
    • Functional Ingredients
    • Actives
    • Polymers
    Suggested For You
    10 Beauty Product Marketing Claims Deconstructed 10 Beauty Product Marketing Claims Deconstructed
    PCPC To Host Legal & Regulatory Conference PCPC To Host Legal & Regulatory Conference
    FDA Sends Warning Letter To Topical Pain Treatment Maker FDA Sends Warning Letter To Topical Pain Treatment Maker
    FDA Commissioner Tweets About Cosmetics FDA Commissioner Tweets About Cosmetics
    Asbestos? In Cosmetics? Asbestos? In Cosmetics?
    Read FDA Read FDA's Statement on Cosmetics Safety
    FDA Commissioner To Resign, Reports Say FDA Commissioner To Resign, Reports Say
    FDA Issues New Warning Letters FDA Issues New Warning Letters
    FDA Issues Letter to Soleo of Korea FDA Issues Letter to Soleo of Korea
    J&J Pushes Back on Reuters Article J&J Pushes Back on Reuters Article
    ACI Approves FDA Proposal for Food Handler Antiseptics ACI Approves FDA Proposal for Food Handler Antiseptics
    Lipotec USA, Inc. Lipotec USA, Inc.
    FDA Issues RFI on Food Handler Antiseptics FDA Issues RFI on Food Handler Antiseptics
    Some Gut Feelings Regarding the Microbiome Some Gut Feelings Regarding the Microbiome
    FDA Seeks Comments on Proposed Consumer Survey about Allergens in Cosmetics FDA Seeks Comments on Proposed Consumer Survey about Allergens in Cosmetics

    Related Sunscreen Filter

    • Actives | Sun Care
      The Final Monograph Is Upon Us!

      The Final Monograph Is Upon Us!

      These are difficult times for the sunscreen industry. First, we were faced with the prospects of no Final Monograph in sight and no Time and Extent Application (TEA) filters to improve the protection of US consumers especially from the UVA solar radi…
      Nadim Shaath, Alpha Research & Development Ltd 12.02.19

    • Actives | Polymers | Sun Care

      Another FDA Delay Is Coming Our Way

      What are the odds that the US Food and Drug Administration will issue the Final Monograph on November 26, 2019? The Sunscreen Innovations Act (SIA) of November 26, 2014 mandates its release within five years from that date. Additionally, the FDA rele…
      Nadim Shaath, Alpha Research & Development Ltd 06.03.19

    • Actives | Sun Care

      US Government Shutdown Imperils Reform Hopes

      Happy New Year! A new US Congress has been sworn in and, at press time, it is facing major political challenges over the border wall and ensuing federal government shutdown. Guess what will also suffer? The OTC Reform Act. As of Jan. 8, 2019, both th…
      Nadim Shaath, Alpha Research & Development Ltd 02.01.19


    • Actives | Functional Ingredients | Polymers | Sun Care

      The Sunrise & Sunset of Sunscreens

      We’re well into the dog days of summer in the Northern Hemisphere and there are lots of activities involving the use of sunscreens for protection from the scathing sun. Consumer Reports revealed its top-rated sunscreens for 2018. The Environmen…
      Nadim Shaath, Alpha Research & Development Ltd 08.03.18

    • Actives | Sun Care

      Will Hawaii Bring Down The Sunscreen Industry?

      Citing serious, long-term environmental damage to coral reefs and to the oceans, Hawaii lawmakers passed a bill in May that bans the use of two ultraviolet filters, oxybenzone and octinoxate. If this bill is signed by Hawaii’s governor, the ban…
      Nadim Shaath, Alpha Research & Development Ltd 06.01.18

    • Actives | Functional Ingredients | Polymers | Skin Care | Sun Care

      R&D Efforts Move Along Even as Regulators Stall

      I am getting tired of reporting on the developments—more accurately, the lack of developments—on sunscreen regulations in the US! The snail-paced movement toward final regulations is only contributing to the lack of reporting on the progr…
      Nadim Shaath, Alpha Research & Development Ltd 04.02.18


    • Sun Care

      Sunscreen Legislation Shows No Signs of Heating Up

      The Society of Cosmetic Chemists’ 71st Annual Scientific Meeting and Technology Showcase was held for the first time at the Times Square Westin Hotel in New York City on Dec. 11-12, 2017. The proceedings were slightly delayed on the first day d…
      Nadim Shaath, Alpha Research & Development Ltd 02.01.18

    • Actives | Sun Care

      We Need Good News And Better Research!

      It has been more than 15 years now since the first three Time and Extent Application (TEA) ingredients were filed with the US Food and Drug Administration (FDA), yet to date, no final decision has been reached. The Sunscreen Innovation Act (SIA) was…
      Nadim Shaath, Alpha Research & Development Ltd 12.01.17

    • Actives | Sun Care

      Over-the-Counter (OTC) Monograph Reform

      Congress is currently debating how to amend the Federal Food, Drug and Cosmetic Act to clarify the regulatory framework with respect to certain non-prescription drugs that are marketed without an approved new drug application. The proposed bill will…
      Nadim Shaath, Alpha Research & Development Ltd 10.02.17


    • Actives | Sun Care

      The Case for Sunscreens

      My previous column posed the question: Who needs sunscreens? The Skin Cancer Foundation (SCF) and the American Academy of Dermatology (AAD) both answer with an emphatic “Everyone!”1,2 Sunscreen use can help prevent skin cancer by protecti…
      Nadim Shaath, Alpha Research & Development Ltd 08.01.17

    • Actives | Sun Care

      Are The Odds Stacked Against Sunscreen Use?

      Recent calls echo loud and clear against the safe, effective use of sunscreens to prevent skin cancer. They emanate from the four corners of the world and include the US Food and Drug Administration (FDA), environmentalists worldwide, and even toxico…
      Nadim Shaath, Alpha Research & Development Ltd 06.01.17

    • Actives | Sun Care
      Recent Developments in Sunscreens

      Recent Developments in Sunscreens

      FDA continues to treat sunscreens as drugs; expecting the full complement of drug tests that any cancer drug requires.
      Nadim Shaath, PhD, Alpha Research & Development Ltd. 04.03.17

    • Actives | Sun Care

      Some Positive Developments In the Sun Care Industry

      In my previous column (August 2016) we played the blame game in the sunscreen industry. I highlighted many of the negative developments in the industry and who was responsible for this perceived deterioration in the protection of our consumers from t…
      Nadim Shaath, Alpha Research & Development Ltd 10.03.16

    • Actives | Polymers | Sun Care | Testing

      No Dearth of Players For the Blame Game

      This column will tackle the problems with sun care protection in general. My next column will address the solutions for better sun care protection. Fifty years ago our sunscreen industry began to grow. In 1966, the consumer demanded protection from t…
      Nadim Shaath, Alpha Research & Development Ltd 08.01.16

    • Actives | Functional Ingredients | Sun Care
      A Forum for Sunscreen: Debating Better Protection

      A Forum for Sunscreen: Debating Better Protection

      Vital issues confronting the sun care market in the US will be discussed at a round table panel discussion during this month’s Sunscreen Symposium by the Florida Chapter of the Society of Cosmetic Chemists.1 It is the third time such a forum ha…
      Nadim Shaath 09.04.13

    Breaking News
    • Jennifer Garner Joins Virtue Labs
    • Perfect Corp. Partners with Sally Beauty
    • Dollar General To Sell CBD Beauty
    • Nouryon Introduces Natural Starch for Personal Care
    • IFSCC Congress 2020 Yokohama
    View Breaking News >
    CURRENT ISSUE

    December 2019

    • In Sickness & in Health
    • In Action
    • Tress Test
    • From Hollywood to Hair Color
    • Virtual Reality for Makeup Is Not Make Believe
    • Members of the Club
    • A New Era in Efficacy Testing
    • View More >
    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Deerland Obtains Certification from Australia’s Therapeutic Goods Administration
    OptiMSM Shown to Improve Hair & Nail Appearance and Condition
    DCC Acquires Contract Manufacturer Ion Laboratories
    Coatings World

    Latest Breaking News From Coatings World

    Palmer Holland Expands Sales Team into Canada
    Axalta Reports 'Oustanding' Feedback on Award-Winning Voltatex 4224
    Sika Opens 3rd Indonesian Plant
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FDA Approves First Nasal Rescue Treatment for Frequent Seizure Activity
    Lens-Free Microendoscope Generates High Quality Images
    Roche's Blood Glucose Reading Smartphone App Gains CE Mark
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Charles River, Bit Bio Enter Strategic Partnership
    Parexel Adds Experts to Regulatory Consulting Group
    Catalent, Bridge Therapeutics Execute Exclusive License Agreement
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    CES 2020 Preview - Innovation Award Honorees in Health & Wellness
    Star of E!'s Botched Gets Line Leaping Bunny Certified
    Verve Medical Cosmetics Celebrates 20 Years
    Happi

    Latest Breaking News From Happi

    Jennifer Garner Joins Virtue Labs
    Perfect Corp. Partners with Sally Beauty
    Dollar General To Sell CBD Beauty
    Ink World

    Latest Breaking News From Ink World

    ePac Flexible Packaging Expands into Asia Pacific Market
    Palmer Holland Expands Sales Team into Canada
    Koenig & Bauer Promotes Preston Neetzel to Director of Flexo Sales
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Domino welcomes Steve Daily to Service & Support Team
    Kodak and Uteco sell first Ultrastream flexible packaging press
    Archroma announces CEO transition
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    AATC Adds Two Scholarships
    Archroma Names CEO
    Fitesa Buys Freudenberg's South American Hygiene Business
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA OKs Shoulder Innovations' Augmented Glenoids for Total Shoulder System
    OrthoGrid Systems Receives FDA 510(k) Clearance for New PhantomMSK Trauma Application
    Tyber Medical Opens $8M Office and Manufacturing Facility
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Ynvisible, Identiv Partner
    Tom Peregoodoff Appointed CEO of TF Massif Technologies
    Osram’s Managing Board Invites ams to Talks About Future

    Copyright © 2019 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.